Design
Review
Authors
Loading...
May support ACE inhibitor preference in CVD and diabetes; leaves open kinin system contributions for prospective trials.
Key points are not available for this paper at this time.
Regoli et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: